Fig. 2: Kaplan–Meier cancer-specific survival estimates for small bowel adenocarcinoma (SBA) patients.

Survival estimates by etiologic group a, stage b, tumor-infiltrating lymphocyte (TIL) density c, microsatellite instability (MSI) status d, histotype e, and CDX2 expression f). CeD-SBA, celiac disease-associated small bowel adenocarcinoma; CrD-SBA, Crohn’s disease-associated small bowel adenocarcinoma.